Cymbalta Eases Back Pain In Study

Mon Aug 25, 2008

NEW YORK (Reuters) – Eli Lilly and Co’s Cymbalta depression treatment significantly reduced chronic low back pain in a relatively small clinical trial, the company said on Monday.

Data from the 236-patient trial, which lasted 13 weeks and compared the effectiveness of Cymbalta with placebos, were presented at the annual congress of the European Federation of Neurological Societies in Madrid. More…

PainCareMD